CN Patent

CN112043681A — 一种拉考沙胺药物组合物及其药物制剂

Assigned to Shanghai Aokeda Pharmaceutical Technology Co ltd · Expires 2020-12-08 · 5y expired

What this patent protects

本发明涉及一种拉考沙胺药物组合物及其药物制剂。所述药物组合物包含缓释多颗粒，其中所述缓释多颗粒的每个包含：(a)载药核芯，其包含拉考沙胺或其药学上可接受的盐；和(b)包裹所述载药核芯的缓释层。本发明还提供一种口服一日一次的拉考沙胺缓释制剂。

USPTO Abstract

本发明涉及一种拉考沙胺药物组合物及其药物制剂。所述药物组合物包含缓释多颗粒，其中所述缓释多颗粒的每个包含：(a)载药核芯，其包含拉考沙胺或其药学上可接受的盐；和(b)包裹所述载药核芯的缓释层。本发明还提供一种口服一日一次的拉考沙胺缓释制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN112043681A
Jurisdiction
CN
Classification
—
Expires
2020-12-08
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Aokeda Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.